NO953349L - Kombinasjonsterapi av human cancer med cisplatin/tamoxifen - Google Patents

Kombinasjonsterapi av human cancer med cisplatin/tamoxifen

Info

Publication number
NO953349L
NO953349L NO953349A NO953349A NO953349L NO 953349 L NO953349 L NO 953349L NO 953349 A NO953349 A NO 953349A NO 953349 A NO953349 A NO 953349A NO 953349 L NO953349 L NO 953349L
Authority
NO
Norway
Prior art keywords
tamoxifen
cisplatin
combination therapy
human cancer
cancer
Prior art date
Application number
NO953349A
Other languages
English (en)
Other versions
NO953349D0 (no
Inventor
Edward F Mcclay
Stephen Barnard Howell
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of NO953349L publication Critical patent/NO953349L/no
Publication of NO953349D0 publication Critical patent/NO953349D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO953349A 1993-02-26 1995-08-25 Kombinasjonsterapi av human cancer med cisplatin/tamoxifen NO953349D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2327193A 1993-02-26 1993-02-26
PCT/US1994/002132 WO1994018990A1 (en) 1993-02-26 1994-02-25 Combination cisplatin/tamoxifen therapy for human cancers

Publications (2)

Publication Number Publication Date
NO953349L true NO953349L (no) 1995-08-25
NO953349D0 NO953349D0 (no) 1995-08-25

Family

ID=21814106

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953349A NO953349D0 (no) 1993-02-26 1995-08-25 Kombinasjonsterapi av human cancer med cisplatin/tamoxifen

Country Status (12)

Country Link
US (1) US6288111B1 (no)
EP (1) EP0686038A4 (no)
JP (1) JPH08507079A (no)
KR (1) KR960700734A (no)
AU (1) AU692763B2 (no)
CA (1) CA2156826A1 (no)
IL (1) IL108722A (no)
NO (1) NO953349D0 (no)
NZ (1) NZ262825A (no)
SA (1) SA94140746B1 (no)
WO (1) WO1994018990A1 (no)
ZA (1) ZA941290B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US6274576B1 (en) 1995-06-27 2001-08-14 The Henry Jackson Foundation For The Advancement Of Military Medicine Method of dynamic retardation of cell cycle kinetics to potentiate cell damage
CA2225682A1 (en) * 1995-06-27 1997-01-16 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method of dynamic retardation of cell cycle kinetics to potentiate cell damage
ATE241975T1 (de) 1998-08-25 2003-06-15 Deutsches Krebsforsch Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung
AU6291699A (en) * 1998-10-06 2000-04-26 Kgk Synergize Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin
RS37804A (en) * 2001-11-01 2006-12-15 Mark Vincent Use of n,n-diethyl-2-/-4-(phenylmethyl)- phenoxy/ethanamine monohydrochloride (dppe)in cancer therapy
WO2014081029A1 (ja) * 2012-11-26 2014-05-30 学校法人近畿大学 抗がん剤による末梢神経障害の予防、治療、または軽減剤
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen

Also Published As

Publication number Publication date
US6288111B1 (en) 2001-09-11
ZA941290B (en) 1995-08-25
NZ262825A (en) 1997-06-24
CA2156826A1 (en) 1994-09-01
WO1994018990A1 (en) 1994-09-01
JPH08507079A (ja) 1996-07-30
IL108722A (en) 2000-07-26
EP0686038A4 (en) 1998-05-20
EP0686038A1 (en) 1995-12-13
IL108722A0 (en) 1994-05-30
AU692763B2 (en) 1998-06-18
NO953349D0 (no) 1995-08-25
KR960700734A (ko) 1996-02-24
AU6273294A (en) 1994-09-14
SA94140746B1 (ar) 2004-08-31

Similar Documents

Publication Publication Date Title
DE69525347D1 (de) Krebsbehandlung mittels humanen choriongonadotropin
BR9508886A (pt) Compostos e métodos para o tratamento de câncer
DK0562759T3 (da) Interstitiel røntgennål
CY2008007I2 (el) Χρηση του et743 στην συνδυαστικη θεραπεια με δεξαμεθαζονη για την θεραπευτικη αγωγη του καρκινου
DK90089D0 (da) Hudbehandlingspraeparat
ID18679A (id) Penggunaan terapi lanjutan
DK279886A (da) Human tumornekrosefaktor
NO953349L (no) Kombinasjonsterapi av human cancer med cisplatin/tamoxifen
DE69214558D1 (de) Krebstherapiesystem
DE69218229T2 (de) Entschwefelungsbehandlung
IL116733A0 (en) The use of sertraline to treat cancer patients
NO981822D0 (no) Anvendelse av proteinet GAX for behandling av cancer
NO20014228D0 (no) Radioaktiv cisplatin i behandling av cancer
ZA95508B (en) Use of flavolignans as adjuvants in tumour therapy
DE9419997U1 (de) Kältetherapiekammer
KR940005082U (ko) 전신 쑥뜸기
DK85290A (da) Terapeutisk virksomme forbindelser
DK194590A (da) Cancerterapeutikum
DE9312268U1 (de) Orthopädischer Therapie-Innenschuh
KR950016727U (ko) 온침치료기
KR940000387U (ko) 온열 전위 치료기
NO923108D0 (no) Hudpleie-behandling
ATE212858T1 (de) Krebsbehandlung mittels humanen choriongonadotropin
KR940020248U (ko) 원적외선 방사 세라믹이 첨가된 의료용 밴드
SE8604881D0 (sv) Alkylglycerolernas effekt vid cancerterapi